Information about GlobalPharmacyMeds.to
List of countries where we can ship Lurasidone:
Latest news releases on Lurasidone:
Lurasidone (/ lj ʊəˈr æ s ɪ d oʊ n /; trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S.
Medscape - Schizophrenia and bipolar I depression dosing for Latuda (lurasidone), frequency-based adverse effects, comprehensive interactions, contraindications ...
Physician reviewed lurasidone patient information - includes lurasidone description, dosage and directions.
Lurasidone is FDA approved for use in pediatric patients 10 years of age and older with bipolar I depression and adolescents 13 years and older with schizophrenia.
Il Lurasidone, nome commerciale LATUDA™, è un farmaco antipsicotico indicato, per il momento, nel trattamento della Schizofrenia .
New Atypical Antipsychotic Lurasidone Appears To Improve Schizophrenia Without Weight-Gain Side Effects
Latuda 18.5mg, 37mg and 74mg film-coated tablets - Summary of Product Characteristics (SmPC) by Sunovion Pharmaceuticals Europe Ltd
Latuda® is an atypical antipsychotic indicated for the treatment of depressive episode associated with bipolar depression in both adult and pediatric patients (10 to ...
You may be eligible for LATUDA copay savings in just three easy steps. Fill out the copay savings registration form and find out more.
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS; and SUICIDAL THOUGHTS AND BEHAVIORS. Increased risk of death in elderly people with dementia ...